Back to Search
DANIEL RYAN, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1780925016Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors.
PMID 17036355·Cancer·2006
3-trial
A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors.
PMID 17075878·Cancer·2006
3-trial
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 given as a 1-hour intravenous infusion in patients with advanced solid tumors.
PMID 15073096·Clin Cancer Res·2004
3-trial
A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer.
PMID 14533439·Cancer Invest·2003
3-trial
A phase II and pharmacokinetic study of ecteinascidin 743 in patients with gastrointestinal stromal tumors.
PMID 12490740·Oncologist·2002
3-trial
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.
PMID 11815964·Cancer·2002
3-trial
Management of locally advanced adenocarcinoma of the pancreas.
PMID 12063831·Hematol Oncol Clin North Am·2002
6-review
Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies.
PMID 11234874·Clin Cancer Res·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1202 S JAMES CAMPBELL BLVD
COLUMBIA, TN 38401 - Phone
- (931) 380-0599
Quick Facts
- NPI
- 1780925016
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile